The immunogenicity and safety of an investigational meningococcal serogroups A, C, W-135, Y tetanus toxoid conjugate vaccine (ACWY-TT) compared with a licensed meningococcal tetravalent polysaccharide vaccine: a randomized, controlled non-inferiorit (Q36391883)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	The immunogenicity and safety of an investigational meningococcal serogroups A, C, W-135, Y tetanus toxoid conjugate vaccine (ACWY-TT) compared with a licensed meningococcal tetravalent polysaccharide vaccine: a randomized, controlled non-inferiorit	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

The immunogenicity and safety of an investigational meningococcal serogroups A, C, W-135, Y tetanus toxoid conjugate vaccine (ACWY-TT) compared with a licensed meningococcal tetravalent polysaccharide vaccine: a randomized, controlled non-inferiorit (English)

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

1 reference

based on heuristic

inferred from title

tetanus vaccine

1 reference

based on heuristic

inferred from title

author name string

Ghassan Dbaibo

1

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Noel Macalalad

2

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Mari Rose Aplasca-De Los Reyes

3

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Efren Dimaano

4

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Veronique Bianco

5

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Yaela Baine

6

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Jacqueline Miller

7

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

publication date

9 April 2012

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Human Vaccines & Immunotherapeutics

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

8

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

7

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

873-880

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Tetravalent meningococcal serogroups A, C, W-135 and Y conjugate vaccine is well tolerated and immunogenic when co-administered with measles-mumps-rubella-varicella vaccine during the second year of life: An open, randomized controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3495723

30 September 2017

Hyporesponsiveness and its clinical implications after vaccination with polysaccharide or glycoconjugate vaccines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3495723

30 September 2017

Safety and immunogenicity of a tetravalent meningococcal serogroups A, C, W-135 and Y conjugate vaccine in adolescents and adults

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3495723

30 September 2017

Invasive meningococcal disease and travel

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3495723

30 September 2017

Changes in Neisseria meningitidis disease epidemiology in the United States, 1998-2007: implications for prevention of meningococcal disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3495723

30 September 2017

Quadrivalent meningococcal vaccination of adults: phase III comparison of an investigational conjugate vaccine, MenACWY-CRM, with the licensed vaccine, Menactra

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3495723

30 September 2017

The epidemiology of pneumococcal, meningococcal, and Haemophilus disease in the Middle East and North Africa (MENA) region--current status and needs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3495723

30 September 2017

Meningococcal surrogates of protection--serum bactericidal antibody activity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3495723

30 September 2017

Global epidemiology of meningococcal disease and vaccine efficacy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3495723

30 September 2017

Validation of serological correlate of protection for meningococcal C conjugate vaccine by using efficacy estimates from postlicensure surveillance in England

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3495723

30 September 2017

Serogroup W-135 meningococcal disease during the Hajj, 2000

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3495723

30 September 2017

Chronicle of an outbreak foretold: meningococcal meningitis W135 in Burkina Faso

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3495723

30 September 2017

Safety, reactogenicity, and immunogenicity of a tetravalent meningococcal polysaccharide-diphtheria toxoid conjugate vaccine given to healthy adults

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3495723

30 September 2017

Prospective study of a serogroup X Neisseria meningitidis outbreak in northern Ghana

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3495723

30 September 2017

Planning, registration, and implementation of an immunisation campaign against meningococcal serogroup C disease in the UK: a success story

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3495723

30 September 2017

Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays. The Multilaboratory Study Group.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3495723

30 September 2017

Increase in Neisseria meningitidis serogroup W135, Niger, 2010.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3495723

28 June 2018

Global epidemiology of meningococcal disease.

1 reference

https://api.crossref.org/works/10.4161%2FHV.20211

21 January 2018

Hajj-associated outbreak strain of Neisseria meningitidis serogroup W135: estimates of the attack rate in a defined population and the risk of invasive disease developing in carriers.

1 reference

https://api.crossref.org/works/10.4161%2FHV.20211

21 January 2018

Induction of immunologic refractoriness in adults by meningococcal C polysaccharide vaccination.

1 reference

https://api.crossref.org/works/10.4161%2FHV.20211

21 January 2018

Immunogenicity of a single dose of tetravalent meningococcal serogroups A, C, W-135, and Y conjugate vaccine administered to 2- to 10-year-olds is noninferior to a licensed-ACWY polysaccharide vaccine with an acceptable safety profile

1 reference

https://api.crossref.org/works/10.4161%2FHV.20211

21 January 2018

Immunogenicity and safety of a meningococcal A conjugate vaccine in Africans.

1 reference

https://api.crossref.org/works/10.4161%2FHV.20211

21 January 2018

Safety, immunogenicity, and immune memory of a novel meningococcal (groups A, C, Y, and W-135) polysaccharide diphtheria toxoid conjugate vaccine (MCV-4) in healthy adolescents.

1 reference

https://api.crossref.org/works/10.4161%2FHV.20211

21 January 2018

Meningococcal vaccines: polysaccharide and polysaccharide conjugate vaccines

1 reference

https://pubmed.ncbi.nlm.nih.gov/22485050

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of enzyme-linked immunosorbent assay (ELISA) with the toxin neutralization test in mice as a method for the estimation of tetanus antitoxin in human sera

1 reference

https://pubmed.ncbi.nlm.nih.gov/22485050

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Meningococcal Meningitis: Unprecedented Incidence of Serogroup X--Related Cases in 2006 in Niger

1 reference

https://pubmed.ncbi.nlm.nih.gov/22485050

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety, immunogenicity, and antibody persistence of a new meningococcal group A conjugate vaccine in healthy Indian adults

1 reference

https://pubmed.ncbi.nlm.nih.gov/22485050

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunogenicity, reactogenicity and persistence of meningococcal A, C, W-135 and Y-tetanus toxoid candidate conjugate (MenACWY-TT) vaccine formulations in adolescents aged 15–25 years

1 reference

https://pubmed.ncbi.nlm.nih.gov/22485050

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A dose-range study assessing immunogenicity and safety of one dose of a new candidate meningococcal serogroups A, C, W-135, Y tetanus toxoid conjugate (MenACWY-TT) vaccine administered in the second year of life and in young children

1 reference

https://pubmed.ncbi.nlm.nih.gov/22485050

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunogenicity and tolerability of a quadrivalent meningococcal glycoconjugate vaccine in children 2-10 years of age

1 reference

https://pubmed.ncbi.nlm.nih.gov/22485050

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety and immunogenicity of an investigational quadrivalent meningococcal CRM(197) conjugate vaccine, MenACWY-CRM, compared with licensed vaccines in adults in Latin America

1 reference

https://pubmed.ncbi.nlm.nih.gov/22485050

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunogenicity and safety of an investigational quadrivalent meningococcal ACWY tetanus toxoid conjugate vaccine in healthy adolescents and young adults 10 to 25 years of age

1 reference

https://pubmed.ncbi.nlm.nih.gov/22485050

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An investigational tetravalent meningococcal serogroups A, C, W-135 and Y-tetanus toxoid conjugate vaccine co-administered with Infanrix™ hexa is immunogenic, with an acceptable safety profile in 12-23-month-old children

1 reference

https://pubmed.ncbi.nlm.nih.gov/22485050

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.4161/HV.20211

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36391883&oldid=1562885389"